ATP5PO and Meniere disease: From our identified miRNAs, miRNA-1299 was identified as the most promising biomarker for Menière's disease since it is differentially regulated in both perilymph and serum of Menière's patients, and is predicted to target R3HDM2, SCP2, and ATP5PO mRNA.